Systematic evaluation of efficacy and safety of noacs in atrial fibrillation therapy

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-147
• By: ZENG, Yingtong (Guangdong General Hospital Guangdong Academy Institute)
• Co-author(s): Yingtong Zeng: Pharmacy department, Guangdong General Hospital Guangdong Academy of Medical Sciences, Guangzhou, China
  Weihua Lai: Pharmacy department, Guangdong General Hospital Guangdong Academy of Medical Sciences, Guangzhou, China
  Jing Zhou: Pharmacy department, Guangdong General Hospital Guangdong Academy of Medical Sciences, Guangzhou, China
  Yi Yang: Pharmacy department, Guangdong General Hospital Guangdong Academy of Medical Sciences, Guangzhou, China
  
• Abstract:

  Background

  Non-Vitamin K antagonist oral anticoagulants (NOACs) are now widely used in patients with non-valvular atrial fibrillation (AF)s. NOACs include dabigatran, apixaban，rivaroxaban and edoxaban.

  Methods

  The randomized controlled trials of NOACs versus warfarin in the treatment of atrial fibrillation,which had been published from the time of
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login